Mineralys Therapeutics, Inc.

Direct answer

Mineralys Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MLYS.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally...

Can you invest in Mineralys Therapeutics, Inc.?

Yes. Mineralys Therapeutics, Inc. trades publicly on NASDAQ as MLYS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Mineralys Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.